Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| THH | TryHard | $15.33 | -$16.67 | -52.09% | 2.1M | $1.6B | $4.00$55.05 |
| MTVA | MetaVia | $3.42 | -$2.00 | -36.90% | 1.6M | $13M | $3.00$23.54 |
| AGEN | Agenus | $3.71 | -$0.97 | -20.73% | 2.6M | $159M | $1.38$7.34 |
| SDOT | Sadot Group | $2.62 | -$0.62 | -19.04% | 127K | $5.0M | $1.17$35.80 |
| BGL | Blue Gold | $2.12 | -$0.49 | -18.77% | 263.9K | $81M | $1.83$166.50 |
| RDTL | GraniteShares ETF Trust - GraniteShares 2x Long Rddt Daily ETF | $48.59 | -$11.16 | -18.68% | 701.7K | - | $9.72$89.84 |
| FBYD | Falcon's Beyond Global | $7.05 | -$1.55 | -18.02% | 3.4K | $416M | $3.62$29.02 |
| DGNX | Diginex | $2.20 | -$0.46 | -17.29% | 3.4M | $537M | $0.45$39.85 |
| AFJK | Aimei Health Technology | $47.28 | -$9.32 | -16.46% | 16.6K | $346M | $6.75$130.37 |
| OKYO | Okyo Pharma | $2.42 | -$0.41 | -14.49% | 264.3K | $106M | $0.90$3.35 |
Related Articles
Featured Article
This Stock Soared 9,800% in 2025. Here's 1 Key Reason Why Investors Are Piling In (Spoiler: It's Regencell Bioscience Holdings (RGC) Stock)
Selena Maranjian|Nov 24, 2025
Is the stock likely to keep surging? The answer seems pretty clear.
3 Magnificent Growth Stocks to Buy Hand Over Fist
George Budwell, PhD|May 22, 2024
Small-cap stocks could get a boost from the central bank's anticipated rate cuts in 2025. These three stocks may be a great way to get ahead of this catalyst.
Up 40%: Is This Red-Hot Growth Stock Still a Buy?
George Budwell, PhD|Apr 28, 2024
This small-cap biotech stock is surging. Time to buy?
Advertisement
Down 75%. Is Agenus Stock a Buy on the Dip?
Cory Renauer|Apr 8, 2024
Wall Street analysts who watch the cancer drug developer closely think it could rocket higher.
2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street
George Budwell, PhD|Dec 24, 2023
These two biotech stocks could be poised for a trend reversal.
3 Magnificent Growth Stocks to Buy on the Dip
George Budwell, PhD|Aug 28, 2023
These three biotech stocks are attractive buys right now.
2 Low-Priced Stocks That Could Make You Richer
George Budwell, PhD|Jun 26, 2023
These two low-priced healthcare stocks could skyrocket within the next 12 months.
Better Recovery-Story Buy: Emergent BioSolutions or Invitae?
Adria Cimino|Jun 26, 2023
Both of these stocks have plummeted more than 50% over the past year.
Is Emergent BioSolutions Stock a Buy Now?
Alex Carchidi|Jun 9, 2023
The deluge of bad news seems to be over, and a recovery could be in the works.
Down 75%, Can Emergent BioSolutions Turn Things Around?
David Jagielski, CPA|Jun 7, 2023
Has the stock finally bottomed out?
